Titre:
  • Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Auteur:Calati, Raffaella; Crisafulli, Concetta; Balestri, Martina; Serretti, Alessandro; Spina, Edoardo; Calabrò, Marco; Sidoti, Antonina; Albani, Diego; Massat, Isabelle; Höfer, Peter; Amital, Daniela; Juven-Wetzler, Alzbeta; Kasper, Siegfried; Zohar, Joseph; Souery, Daniel; Montgomery, Stuart; Mendlewicz, Julien
Informations sur la publication:Progress in neuro-psychopharmacology & biological psychiatry, 44, page (271-278)
Statut de publication:Publié, 2013-07
Sujet CREF:Sciences humaines
Mots-clés:CREB1
Major depressive disorder
MAPK1
Remission
Response
Treatment resistance
MeSH keywords:Adult
Aged
Antidepressive Agents -- therapeutic use
Cyclic AMP Response Element-Binding Protein -- genetics
Depressive Disorder, Treatment-Resistant -- genetics
Europe
Female
Gene Frequency
Genetic Predisposition to Disease
Genetic Testing
Genotype
Humans
Male
Middle Aged
Mitogen-Activated Protein Kinase 1 -- genetics
Mood Disorders -- genetics
Pharmacogenetics
Polymorphism, Single Nucleotide -- genetics
Note générale:Journal Article
Multicenter Study
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0278-5846
info:doi/10.1016/j.pnpbp.2013.03.005
info:pii/S0278-5846(13)00063-8
info:scp/84876335561
info:pmid/23537502